1 World Health Organization.Compreliensive cervical cancer control-A guide to essential practice,2006:3-11,127-46.
2 乐杰主编.妇产科学.第7版.北京:人民卫生出版社,2010:261-268.
3 Leinonen MK,Nieminen P,Lnnberg S,et al.Detection rates of precancerous and cancerous cervical lesions witlhin one screening round of primary liuman papillomavirus DNA testing:prospective randomised trial in Finland.BMJ,2012,345:e7789.
4 Herfs M,Yamamoto Y,Laury A,et al.A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer.Proc Natl Acad Sci USA,2012,26,109:10516-10521.
5 钟泽艳,赵花,钟兴明,等.广东省流动人口育龄妇女HPV感染状况调查.中国妇幼保健,2013,28:1635-1637.
6 吴晓箐,谈军,李优云,等.广州市白云区流动人日育龄妇女HPV感染及宫颈病变的流行病学调查.中国计划生育和妇产科,2013,5:22-25.
7 吕慧玲,韩临晓,刘燕燕,等.东莞地区己婚育龄妇女人乳头状瘤病毒感染因素及分布情况.中国医药导报,2012,9:138-140.
8 韩秀玲,李世辉,宋忱,等.唐山地区育龄妇女人乳头瘤病毒感染状况分析.广东医学,2011,32:875-876.
9 De Sanjose S,Quint WG,Alemany L,et al.Human papillomavirus genotype attribution in invasive cervical cancer:a retrospective cross-sectional worldwide study.Lancet Oncol,2010,11:1048-1056.
10 Cuzick J,Bergeron C,von Knebel Doeberitz M,et al.New tecbnologies and procedures for cervical Cancer screening.Vaccine,2012,20:F107-Fl16.
11 Castle PE,Gravitt PE,Wentzensen N,et al.A descriptive analysis of prevalent vs incident cervical intraepithelial neoplasia grade 3 following minor cytologic abnormalities.Am J Clin Pathol,2012,138:241-246.